Literature DB >> 26713776

A review of chemosensory perceptions, food preferences and food-related behaviours in subjects with Prader-Willi Syndrome.

Lorelei Martínez Michel1, Andrea M Haqq2, Wendy V Wismer3.   

Abstract

Hyperphagia and obsessive preoccupation with food are hallmark characteristics of Prader-Willi Syndrome (PWS). Although hyperphagia in PWS is linked to hypothalamic dysfunction, the underlying mechanisms behind this problem are poorly understood. Moreover, our understanding of how chemosensory perceptions and food choice/preferences relate to hyperphagia in individuals with PWS is very limited. This narrative review synthesizes studies that assessed chemosensory perceptions, food choices and food-related behaviours in PWS individuals and highlights knowledge gaps in research for further exploration. Twenty seven publications from relevant databases met inclusion criteria and were organized thematically by study technique in the review. Results suggested that PWS individuals have consistent preferences for sweet tastes and in most studies have exhibited a preference for calorie-dense foods over lower calorie foods. No firm conclusions were drawn concerning the chemosensory perceptions of PWS individuals and their influence on food preferences or choices; chemosensation among PWS individuals is an understudied topic. Current evidence suggests that eating behaviour in PWS is a complex phenomenon that involves a dysfunctional satiation and not excessive hunger. Food preferences, choices, and related behaviours and the impact of these on obesity management in those with PWS remain poorly understood and require further study using validated tools and methodologies.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Chemosensory perception; Food preference; Hyperphagia; Prader-Willi syndrome; Taste disorder

Mesh:

Year:  2015        PMID: 26713776     DOI: 10.1016/j.appet.2015.12.021

Source DB:  PubMed          Journal:  Appetite        ISSN: 0195-6663            Impact factor:   3.868


  7 in total

Review 1.  Energy Metabolism Profile in Individuals with Prader-Willi Syndrome and Implications for Clinical Management: A Systematic Review.

Authors:  Maha Alsaif; Sarah A Elliot; Michelle L MacKenzie; Carla M Prado; Catherine J Field; Andrea M Haqq
Journal:  Adv Nutr       Date:  2017-11-15       Impact factor: 8.701

2.  Hormonal and metabolic effects of carbohydrate restriction in children with Prader-Willi syndrome.

Authors:  Krystal A Irizarry; Diana R Mager; Lucila Triador; Michael J Muehlbauer; Andrea M Haqq; Michael Freemark
Journal:  Clin Endocrinol (Oxf)       Date:  2019-01-31       Impact factor: 3.478

Review 3.  Prader-Willi Syndrome in Adults: An Update On Nutritional Treatment and Pharmacological Approach.

Authors:  Silvia Savastano; Giovanna Muscogiuri; Luigi Barrea; Claudia Vetrani; Danilo Fintini; Giulia de Alteriis; Filippo Maria Panfili; Sarah Bocchini; Ludovica Verde; Annamaria Colao
Journal:  Curr Obes Rep       Date:  2022-09-05

Review 4.  Prader-Willi Syndrome: Possibilities of Weight Gain Prevention and Treatment.

Authors:  Éva Erhardt; Dénes Molnár
Journal:  Nutrients       Date:  2022-05-06       Impact factor: 6.706

Review 5.  Baby food and bedtime: Evidence for opposite phenotypes from different genetic and epigenetic alterations in Prader-Willi and Angelman syndromes.

Authors:  Iiro Ilmari Salminen; Bernard J Crespi; Mikael Mokkonen
Journal:  SAGE Open Med       Date:  2019-01-28

6.  Feeding behaviour, risk-sensitivity and response control: effects of 5-HT2C receptor manipulations.

Authors:  Trevor Humby; Yateen Patel; Jenny Carter; Laura-Jean G Stokes; Robert D Rogers; Lawrence S Wilkinson
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2019-02-18       Impact factor: 6.237

7.  Microbiota profile and efficacy of probiotic supplementation on laxation in adults affected by Prader-Willi Syndrome: A randomized, double-blind, crossover trial.

Authors:  Zainab Alyousif; Jennifer L Miller; Jeremie Auger; Mariana Sandoval; Amanda Piano; Thomas A Tompkins; Wendy J Dahl
Journal:  Mol Genet Genomic Med       Date:  2020-10-25       Impact factor: 2.183

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.